Juliana Friedmann
Corporate Officer/Principal presso Quark Pharmaceuticals, Inc.
Profilo
Juliana Friedmann is currently the Vice President-Strategy & Planning at Quark Pharmaceuticals, Inc. She previously worked as a Principal at Dead Sea Bromine Co. Ltd.
from 1983 to 1998.
Ms. Friedmann received her undergraduate and graduate degrees from Ben-Gurion University of the Negev.
Posizioni attive di Juliana Friedmann
| Società | Posizione | Inizio |
|---|---|---|
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Corporate Officer/Principal | 01/01/1998 |
Precedenti posizioni note di Juliana Friedmann
| Società | Posizione | Fine |
|---|---|---|
Dead Sea Bromine Co. Ltd.
 Dead Sea Bromine Co. Ltd. Chemicals: Major DiversifiedProcess Industries Dead Sea Bromine Co., Ltd. manufactures chemicals and specialty products. It produces bromine, fine and industrial chemicals, clear brine fluids for oil and gas services and water treatment chemicals. The company is headquartered in Beer Sheva, Israel. | Corporate Officer/Principal | 01/01/1998 |
Formazione di Juliana Friedmann
| Ben-Gurion University of the Negev | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |
Dead Sea Bromine Co. Ltd.
Dead Sea Bromine Co. Ltd. Chemicals: Major DiversifiedProcess Industries Dead Sea Bromine Co., Ltd. manufactures chemicals and specialty products. It produces bromine, fine and industrial chemicals, clear brine fluids for oil and gas services and water treatment chemicals. The company is headquartered in Beer Sheva, Israel. | Process Industries |
- Borsa valori
- Insiders
- Juliana Friedmann
